HPTN 083: Injectable PrEP can make breakthrough infections hard to detect
Therapeutic vaccine shows potential for HIV control off treatment in early study
HIV capsid inhibitor offers new option for people with highly resistant HIV
Underlying health conditions play a major role in increased risk of hospitalisation with COVID-19 in people with HIV
Depression, anxiety and loneliness can be improved with mindfulness audio lessons
Resistance testing does not improve viral suppression after first-line failure in South Africa and Uganda
Pronounced racial HIV disparities persist in the US, with some signs of slow improvement
African study confirms dolutegravir for second-line treatment and supports recycling of tenofovir
Alendronate can prevent bone loss in people starting HIV treatment
Reformulated islatravir implant should provide PrEP for over a year
Large numbers now on Descovy PrEP in the United States
By 2030, a quarter of people taking HIV treatment in the US will be over 65 and most will have multiple health concerns
